These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22621940)

  • 21. Cognitive characteristics associated with mild cognitive impairment in Parkinson's disease.
    McKinlay A; Grace RC; Dalrymple-Alford JC; Roger D
    Dement Geriatr Cogn Disord; 2009; 28(2):121-9. PubMed ID: 19690414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationships between extrapyramidal signs and cognitive function in a community-dwelling cohort of patients with Parkinson's disease and normal elderly individuals.
    Richards M; Stern Y; Marder K; Cote L; Mayeux R
    Ann Neurol; 1993 Mar; 33(3):267-74. PubMed ID: 8498810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Closing-in in Parkinson's disease individuals with dementia: An experimental study.
    De Lucia N; Grossi D; Mauro A; Trojano L
    J Clin Exp Neuropsychol; 2015; 37(9):946-55. PubMed ID: 26332174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parkinson's disease-cognitive rating scale: psychometrics for mild cognitive impairment.
    Fernández de Bobadilla R; Pagonabarraga J; Martínez-Horta S; Pascual-Sedano B; Campolongo A; Kulisevsky J
    Mov Disord; 2013 Sep; 28(10):1376-83. PubMed ID: 23873810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of naming impairment among patients with Parkinson's disease without dementia, Parkinson's disease dementia and Alzheimer's disease].
    Gui XH; Wang LP; Wu CL; Sun XF
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(21):1664-7. PubMed ID: 27290706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal degeneration of the basal forebrain predicts subsequent dementia in Parkinson's disease.
    Pereira JB; Hall S; Jalakas M; Grothe MJ; Strandberg O; Stomrud E; Westman E; van Westen D; Hansson O
    Neurobiol Dis; 2020 Jun; 139():104831. PubMed ID: 32145376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.
    Aarsland D; Ballard C; Walker Z; Bostrom F; Alves G; Kossakowski K; Leroi I; Pozo-Rodriguez F; Minthon L; Londos E
    Lancet Neurol; 2009 Jul; 8(7):613-8. PubMed ID: 19520613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Profiling novel metabolic biomarkers for Parkinson's disease using in-depth metabolomic analysis.
    Han W; Sapkota S; Camicioli R; Dixon RA; Li L
    Mov Disord; 2017 Dec; 32(12):1720-1728. PubMed ID: 28880465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dementia Risk Prediction in a Longitudinal Geriatric Parkinson's Disease Cohort: Evaluation and Application of the Montreal Parkinson Risk of Dementia Scale.
    Bohn L; McFall GP; Gee M; Postuma RB; Dixon RA; Camicioli R
    Can Geriatr J; 2023 Mar; 26(1):176-186. PubMed ID: 36865405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument.
    Kalbe E; Calabrese P; Kohn N; Hilker R; Riedel O; Wittchen HU; Dodel R; Otto J; Ebersbach G; Kessler J
    Parkinsonism Relat Disord; 2008; 14(2):93-101. PubMed ID: 17707678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A time-efficient screening tool for activities of daily living functions in Parkinson's disease dementia.
    Sulzer P; Liebig L; Csoti I; Graessel E; Wurster I; Berg D; Liepelt-Scarfone I
    J Clin Exp Neuropsychol; 2020 Oct; 42(8):867-879. PubMed ID: 33043797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropsychological characteristics of preclinical dementia in Parkinson's disease.
    Jacobs DM; Marder K; Côté LJ; Sano M; Stern Y; Mayeux R
    Neurology; 1995 Sep; 45(9):1691-6. PubMed ID: 7675228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study.
    Santangelo G; Vitale C; Picillo M; Moccia M; Cuoco S; Longo K; Pezzella D; di Grazia A; Erro R; Pellecchia MT; Amboni M; Trojano L; Barone P
    Parkinsonism Relat Disord; 2015 Oct; 21(10):1219-26. PubMed ID: 26321021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognition in non-demented Parkinson's disease vs essential tremor: A population-based study.
    Sánchez-Ferro Á; Benito-León J; Louis ED; Contador I; Hernández-Gallego J; Puertas-Martín V; Bermejo-Pareja F
    Acta Neurol Scand; 2017 Nov; 136(5):393-400. PubMed ID: 28261780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.
    Galtier I; Nieto A; Lorenzo JN; Barroso J
    J Clin Exp Neuropsychol; 2016; 38(1):40-50. PubMed ID: 26602176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Multiple Object Test as a Performance Based Tool to Assess Cognitive Driven Activity of Daily Living Function in Parkinson's Disease.
    Glonnegger H; Beyle A; Cerff B; Gräber S; Csoti I; Berg D; Liepelt-Scarfone I
    J Alzheimers Dis; 2016 Jul; 53(4):1475-84. PubMed ID: 27392856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying key multi-modal predictors of incipient dementia in Parkinson's disease: a machine learning analysis and Tree SHAP interpretation.
    McFall GP; Bohn L; Gee M; Drouin SM; Fah H; Han W; Li L; Camicioli R; Dixon RA
    Front Aging Neurosci; 2023; 15():1124232. PubMed ID: 37455938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clock drawing test: is it useful for dementia screening in patients having Parkinson disease with and without depression?
    Riedel O; Klotsche J; Förstl H; Wittchen HU;
    J Geriatr Psychiatry Neurol; 2013 Sep; 26(3):151-7. PubMed ID: 23720572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal study of normal cognition in Parkinson disease.
    Pigott K; Rick J; Xie SX; Hurtig H; Chen-Plotkin A; Duda JE; Morley JF; Chahine LM; Dahodwala N; Akhtar RS; Siderowf A; Trojanowski JQ; Weintraub D
    Neurology; 2015 Oct; 85(15):1276-82. PubMed ID: 26362285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.
    Faust-Socher A; Duff-Canning S; Grabovsky A; Armstrong MJ; Rothberg B; Eslinger PJ; Meaney CA; Schneider RB; Tang-Wai DF; Fox SH; Zadikoff C; Kennedy N; Chou KL; Persad C; Litvan I; Mast BT; Gerstenecker AT; Weintraub S; Reginold W; Marras C
    Dement Geriatr Cogn Disord; 2019; 47(4-6):187-197. PubMed ID: 31315127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.